VolitionRX Ltd (VNRX)

May 10, 2025

VolitionRx (VNRX) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025

May 07, 2025

VolitionRx Updates Progress Of Nu.Q NETs Test Adoption - marketscreener.com

May 07, 2025

May 07, 2025

StockNews.com Begins Coverage on VolitionRx (NYSE:VNRX) - Defense World

May 07, 2025

Apr 29, 2025

VolitionRx (NYSE:VNRX) Coverage Initiated by Analysts at StockNews.com - Defense World

Apr 29, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 23, 2025

VolitionRx enters new sales agreement, terminates old one - Investing.com Australia

Apr 23, 2025

Apr 22, 2025

VolitionRx enters new sales agreement, terminates old one By Investing.com - Investing.com South Africa

Apr 22, 2025

Apr 18, 2025

VolitionRX Ltd (AMEX: VNRX): An Enticing Stock To Watch - stocksregister.com

Apr 18, 2025

Apr 18, 2025

Insider Buying: Reynolds Cameron John, VolitionRX Ltd [VNRX] President and CEO invested 181,818 shares - knoxdaily.com

Apr 18, 2025

Apr 14, 2025

VolitionRx (NYSE:VNRX) Now Covered by StockNews.com - The AM Reporter

Apr 14, 2025

Apr 11, 2025

H.C. Wainwright maintains buy on VolitionRX with $2.50 target By Investing.com - Investing.com South Africa

Apr 11, 2025

Apr 10, 2025

VolitionRx (NYSE:VNRX) Coverage Initiated at HC Wainwright - The AM Reporter

Apr 10, 2025

Apr 10, 2025

What is HC Wainwright’s Estimate for VolitionRx Q1 Earnings? - Defense World

Apr 10, 2025

Apr 10, 2025

VolitionRX stock holds as Benchmark maintains rating - Investing.com Australia

Apr 10, 2025

Apr 09, 2025

VolitionRx (NYSE:VNRX) Now Covered by Analysts at HC Wainwright - Defense World

Apr 09, 2025

Apr 08, 2025

VolitionRX stock holds as Benchmark maintains rating By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Apr 08, 2025

Apr 08, 2025

HC Wainwright Initiates VolitionRx With Buy Rating, $2.50 Price Target - marketscreener.com

Apr 08, 2025

Apr 05, 2025

VolitionRx (NYSE:VNRX) Earns Sell Rating from Analysts at StockNews.com - Defense World

Apr 05, 2025

Apr 04, 2025

VolitionRx Moves to Register Warrant Shares on New Form By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

VolitionRx Moves to Register Warrant Shares on New Form - Investing.com

Apr 04, 2025

Apr 02, 2025

VolitionRx Limited (AMEX:VNRX) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 02, 2025

Apr 01, 2025

VolitionRx Ltd. Earnings Call Highlights Growth and Challenges - TipRanks

Apr 01, 2025

Apr 01, 2025

VolitionRX Ltd (VNRX) Reports Q4 EPS of -0.06, Revenue Surges to $1.2 Million, Exceeding Estimates - GuruFocus

Apr 01, 2025

Apr 01, 2025

VolitionRx (VNRX) Sees Strong Growth with Doubling of Nu.Q Vet T - GuruFocus

Apr 01, 2025

Apr 01, 2025

Earnings call transcript: VolitionRx revenue beats forecast in Q4 2024 - Investing.com India

Apr 01, 2025

Apr 01, 2025

VolitionRX Ltd (VNRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances - Yahoo Finance

Apr 01, 2025

Apr 01, 2025

VolitionRx Limited Reports Strong 2024 Financial Results - TipRanks

Apr 01, 2025

Mar 31, 2025

Volitionrx Ltd earnings missed, revenue fell short of estimates - Investing.com

Mar 31, 2025

Mar 31, 2025

Volitionrx Ltd earnings missed, revenue fell short of estimates By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: VolitionRx revenue beats forecast in Q4 2024 By Investing.com - Investing.com UK

Mar 31, 2025

Mar 31, 2025

VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update - Financial Times

Mar 31, 2025

Mar 28, 2025

A Look Ahead: VolitionRX's Earnings Forecast - Benzinga

Mar 28, 2025

Mar 28, 2025

Volition Announces Two Poster Presentations At Esmo's European Lung Cancer Congress 2025 - MarketScreener

Mar 28, 2025

Mar 27, 2025

Volitionrx director Innes buys $99,999 in common stock By Investing.com - Investing.com Canada

Mar 27, 2025

Mar 27, 2025

VolitionRx CEO Cameron Reynolds acquires $99,999 in stock - Investing.com

Mar 27, 2025

Mar 27, 2025

Volitionrx director Innes buys $99,999 in common stock - Investing.com

Mar 27, 2025

Mar 27, 2025

VolitionRx CEO Cameron Reynolds acquires $99,999 in stock By Investing.com - Investing.com UK

Mar 27, 2025

Mar 26, 2025

VolitionRx secures up to $2.3 million in direct offering By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

VolitionRx secures up to $2.3 million in direct offering - Investing.com India

Mar 26, 2025

Mar 26, 2025

VolitionRx Announces Pricing of up to $2.3 Million Registered Direct Offering - Marketscreener.com

Mar 26, 2025

Mar 25, 2025

VolitionRx Limited Schedules Full Fiscal Year 2024 Earnings Conference Call and Business Update - Yahoo Finance

Mar 25, 2025

Mar 22, 2025

D. Boral Capital Reaffirms “Buy” Rating for VolitionRx (NYSE:VNRX) - Defense World

Mar 22, 2025

Mar 21, 2025

VolitionRX Reports Positive Results of Automated Nu.Q Cancer Immunoassay Test in Development - Marketscreener.com

Mar 21, 2025

Mar 21, 2025

VolitionRx reports results from Nu.Q Cancer test - TipRanks

Mar 21, 2025

Mar 21, 2025

Volition's Nu.Q® Cancer Diagnostics Test Aims To Disrupt the Multi-Billion Dollar Liquid Biopsy Industry - Yahoo Finance

Mar 21, 2025

Mar 20, 2025

Volition Introduces Nu.Q® Cancer Blood Test in New Industry Primer for Lung Cancer - Yahoo Finance

Mar 20, 2025

Mar 18, 2025

Volitionrx announces pricing of public offering of 3.77 mln shares - Reuters

Mar 18, 2025

Mar 17, 2025

Volition Proudly Sponsors the 44th ISICEM Congress - Yahoo Finance

Mar 17, 2025

Mar 17, 2025

VolitionRx (VNRX) Projected to Post Quarterly Earnings on Monday - Defense World

Mar 17, 2025